MRK - Merck & Co., Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow

Income statement

Annual
All numbers in thousands
Revenue31/12/201831/12/201731/12/201631/12/2015
Total revenue42,294,00040,122,00039,807,00039,498,000
Cost of revenue13,488,00012,640,00013,502,00014,423,000
Gross profit28,806,00027,482,00026,305,00025,075,000
Operating expenses
Research development9,652,0009,818,0006,921,0006,613,000
Selling general and administrative9,555,0009,516,0009,313,0009,799,000
Non-recurring----
Others----
Total operating expenses32,695,00031,974,00029,736,00030,835,000
Operating income or loss9,599,0008,148,00010,071,0008,663,000
Income from continuing operations
Total other income/expenses net-898,000-1,627,000-5,412,000-3,262,000
Earnings before interest and taxes9,599,0008,148,00010,071,0008,663,000
Interest expense-772,000-754,000-693,000-672,000
Income before tax8,701,0006,521,0004,659,0005,401,000
Income tax expense2,508,0004,103,000718,000942,000
Minority interest181,000233,000220,00091,000
Net income from continuing ops6,193,0002,418,0003,941,0004,459,000
Non-recurring events
Discontinued operations----
Extraordinary items----
Effect of accounting changes----
Other items----
Net income
Net income6,220,0002,394,0003,920,0004,442,000
Preferred stock and other adjustments----
Net income applicable to common shares6,220,0002,394,0003,920,0004,442,000
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes